Meritage Portfolio Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-78,470
| Closed | -$2.61M | – | 217 |
|
|
2017
Q2 | $2.61M | Buy |
+78,470
| New | +$2.61M | 0.27% | 145 |
|
|
2016
Q4 | – | Sell |
-101,262
| Closed | -$4.66M | – | 200 |
|
|
2016
Q3 | $4.66M | Sell |
101,262
-3,164
| -3% | -$146K | 0.51% | 101 |
|
|
2016
Q2 | $5.25M | Sell |
104,426
-1,335
| -1% | -$67.1K | 0.59% | 66 |
|
|
2016
Q1 | $5.66M | Sell |
105,761
-3,495
| -3% | -$187K | 0.64% | 55 |
|
|
2015
Q4 | $7.17M | Sell |
109,256
-1,220
| -1% | -$80.1K | 0.81% | 28 |
|
|
2015
Q3 | $6.24M | Buy |
110,476
+1,153
| +1% | +$65.1K | 0.72% | 38 |
|
|
2015
Q2 | $6.46M | Sell |
109,323
-1,155
| -1% | -$68.3K | 0.68% | 36 |
|
|
2015
Q1 | $6.88M | Buy |
110,478
+14
| +0% | +$872 | 0.69% | 33 |
|
|
2014
Q4 | $6.35M | Sell |
110,464
-1,615
| -1% | -$92.9K | 0.68% | 34 |
|
|
2014
Q3 | $6.02M | Sell |
112,079
-1,030
| -0.9% | -$55.4K | 0.69% | 38 |
|
|
2014
Q2 | $5.93M | Buy |
113,109
+3,895
| +4% | +$204K | 0.65% | 46 |
|
|
2014
Q1 | $5.77M | Buy |
109,214
+2,585
| +2% | +$137K | 0.69% | 45 |
|
|
2013
Q4 | $4.27M | Sell |
106,629
-5,000
| -4% | -$200K | 0.53% | 94 |
|
|
2013
Q3 | $4.22M | Buy |
111,629
+1,164
| +1% | +$44K | 0.55% | 85 |
|
|
2013
Q2 | $4.33M | Buy |
+110,465
| New | +$4.33M | 0.62% | 60 |
|